KPTI
Karyopharm Therapeutics, Inc.
NasdaqGS
People also watch:XLRNMGNXEPZMOMEDPTCT
7.360.23 (3.23%)

Pre-Market: 7.500.14 (1.90%) as of 8:25 AM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close7.13
Open7.08
Bid7.40 x 1000
Ask7.50 x 100
52wk Range4.83 - 22.61
Day's Range7.08 - 7.38
Volume60,275
Avg Vol (3m)187,773
As of 4:00 PM EDT. Market closed.
  • Benzingalast month

    Karyopharm Commences First Stage Clinical Study With KPT-9274

    Karyopharm Therapeutics Inc. (NASDAQ: KPTI ) revealed the dosing of the first patient in a first stage clinical study evaluating KPT-9274, an oral, first-in-class, dual-acting p21-activated kinase 4 (PAK4) ...

  • Karyopharm Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : KPTI-US : June 13, 2016
    Capital Cubelast month

    Karyopharm Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : KPTI-US : June 13, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Karyopharm Therapeutics, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day Moving […] (Read more...) The post Karyopharm Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : KPTI-US : June 13, 2016 appeared first on CapitalCube.